What the company does
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of T-cell therapies designed for patients with B-cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania.
What the weekly tape is saying
CABA closed the latest completed week at 3.01 USD. The 4-week return is -9.1% and the 12-week return is 2.4%. Trend Signal is active, Market Dynamics is 0.46. Setup signature: Deep recovery attempt with a 45/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2.87 USD
- Vs Trend Line
- 4.9%
- Fair Value
- 7.38 USD
- Vs Fair Value
- -59.2%
- 52W High
- 4.23 USD
- 52W Low
- 1.26 USD
- Drawdown
- -28.8%
- Range Position
- 58.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 39 weeks
- 52W Active Weeks
- 39
- 52W Active Breadth
- 75.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 903 of 1038
- Sector Percentile
- 13.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.46
- 4W MD Change
- -9.5%
- Relative Strength
- 2.64
- 4W RS Change
- -84.2%
- Expectation
- Undecided
- Probability
- 48.23%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 16.5M
- 13W Average
- 16.0M
- 52W Average
- 14.5M
- Vs 13W
- 1.0x
- Vs 52W
- 1.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.8%
- 52W Volatility
- 14.9%
- Upside Weeks
- 24
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 14.1% / -8.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 616.3M
Opportunity signals
- Trend Signal is active with a 39-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3.01 USD | -7.4% | 2.87 USD | 7.38 USD | 0.46 | 2.64 | 16.5M | On |
| 5 Jun 2026 | 3.25 USD | -14.0% | 2.85 USD | 7.45 USD | 0.77 | 13.58 | 18.9M | On |
| 29 May 2026 | 3.78 USD | 3.6% | 2.82 USD | 7.51 USD | 1.13 | 26.10 | 12.9M | On |
| 22 May 2026 | 3.65 USD | 10.3% | 2.82 USD | 7.55 USD | 0.73 | 26.18 | 14.6M | On |
| 15 May 2026 | 3.31 USD | -14.7% | 2.78 USD | 7.59 USD | 0.51 | 16.73 | 21.5M | On |
| 8 May 2026 | 3.88 USD | 32.0% | 2.76 USD | 7.64 USD | 0.58 | 36.89 | 56.7M | On |
| 1 May 2026 | 2.94 USD | -0.3% | 2.71 USD | 7.70 USD | 0.31 | 11.04 | 9.0M | On |
| 24 Apr 2026 | 2.95 USD | -14.2% | 2.69 USD | 7.76 USD | 0.52 | 14.04 | 9.4M | On |
| 17 Apr 2026 | 3.44 USD | 9.9% | 2.67 USD | 7.81 USD | 0.53 | 37.24 | 10.2M | On |
| 10 Apr 2026 | 3.13 USD | 5.7% | 2.63 USD | 7.84 USD | 0.43 | 34.47 | 9.6M | On |
| 2 Apr 2026 | 2.96 USD | 10.4% | 2.59 USD | 7.87 USD | 0.47 | 34.47 | 8.0M | On |
| 27 Mar 2026 | 2.68 USD | -8.8% | 2.55 USD | 7.90 USD | 0.59 | 28.19 | 11.0M | On |
| 20 Mar 2026 | 2.94 USD | -3.9% | 2.51 USD | 7.94 USD | 0.90 | 37.11 | 9.4M | On |
| 13 Mar 2026 | 3.06 USD | -3.5% | 2.46 USD | 7.97 USD | 0.93 | 40.94 | 8.1M | On |